Association of thyroid status prior to transition to end-stage renal disease with early dialysis mortality

被引:11
|
作者
You, Amy S. [1 ]
Sim, John J. [2 ]
Kovesdy, Csaba P. [3 ,4 ]
Streja, Elani [1 ,5 ]
Nguyen, Danh V. [6 ]
Brent, Gregory A. [7 ,8 ]
Kalantar-Zadeh, Kamyar [1 ,5 ]
Rhee, Connie M. [1 ]
机构
[1] Univ Calif Irvine, Harold Simmons Ctr Kidney Dis Res & Epidemiol, Sch Med, Orange, CA 92668 USA
[2] Kaiser Permanente Southern Calif, Dept Nephrol, Los Angeles, CA USA
[3] Univ Tennessee, Ctr Hlth Sci, Div Nephrol, Memphis, TN 38163 USA
[4] Memphis Vet Affairs Med Ctr, Nephrol Sect, Memphis, TN USA
[5] Tibor Rubin Vet Affairs Med Ctr, Long Beach, CA USA
[6] Univ Calif Irvine, Div Gen Internal Med, Orange, CA 92668 USA
[7] Univ Calif Los Angeles, David Geffen Sch Med, Div Endocrinol Diabet & Hypertens, Los Angeles, CA 90095 USA
[8] Vet Affairs Greater Los Angeles Healthcare Syst, Dept Med, Los Angeles, CA USA
基金
美国国家卫生研究院;
关键词
incident ESRD; mortality; pre-ESRD prelude; thyroid; transition; QUALITY-OF-LIFE; SUBCLINICAL HYPOTHYROIDISM; NONTHYROIDAL ILLNESS; FUNCTIONAL DISEASE; KIDNEY-DISEASE; HORMONE LEVELS; DOUBLE-BLIND; RISK-FACTOR; HEMODIALYSIS; TRIIODOTHYRONINE;
D O I
10.1093/ndt/gfy289
中图分类号
R3 [基础医学]; R4 [临床医学];
学科分类号
1001 ; 1002 ; 100602 ;
摘要
Background. Advanced chronic kidney disease (CKD) patients, including those receiving dialysis, have a high prevalence of thyroid dysfunction. Although hypothyroidism is associated with higher death risk in end-stage renal disease (ESRD) patients, no studies have examined whether thyroid status in the pre-ESRD period impacts mortality after dialysis initiation. Methods. Among US veterans with CKD identified from the national Veterans Affairs database that transitioned to dialysis over the period from October 2007 to September 2011, we examined the association of pre-ESRD serum thyrotropin (TSH) levels averaged over the 1-year pre-dialysis ('prelude') period with all-cause mortality in the first year following dialysis initiation. Results. Among 15 335 patients in the 1-year prelude cohort, TSH levels >5.0 mIU/L were associated with higher mortality in expanded case-mix Cox models (reference: TSH 0.5-5.0 mIU/L): adjusted hazard ratio (aHR) [95% confidence interval (CI) 1.20 (1.07-1.33). Similar findings were observed for TSH >5.0 mIU/L and mortality in the 2- and 5-year cohorts: aHRs (95% CI) 1.11 (1.02-1.21) and 1.15 (1.07-1.24), respectively. Analyses of finer gradations of TSH in the 1-year prelude cohort demonstrated that incrementally higher levels >5.0 mIU/L were associated with increasingly higher mortality in expanded case-mix models (reference: TSH 0.5-3.0 mIU/L): aHRs (95% CI) 1.18 (1.04-1.33) and 1.28 (1.03-1.59) for TSH levels >5.0-10.0 mIU/L and >10.0 mIU/L, respectively. In the 2- and 5-year cohorts, mortality associations persisted most strongly for those with TSH >10.0 mIU/L, particularly after laboratory covariate adjustment. Conclusions. Among new ESRD patients, there is a dose-dependent relationship between higher pre-ESRD TSH levels >5.0 mIU/L and post-ESRD mortality. Further studies are needed to determine the impact of TSH reduction with thyroid hormone supplementation in this population.
引用
收藏
页码:2095 / 2104
页数:11
相关论文
共 50 条
  • [21] Race, Mineral Homeostasis and Mortality in Patients with End-Stage Renal Disease on Dialysis
    Scialla, Julia J.
    Parekh, Rulan S.
    Eustace, Joseph A.
    Astor, Brad C.
    Plantinga, Laura
    Jaar, Bernard G.
    Shafi, Tariq
    Coresh, Josef
    Powe, Neil R.
    Melamed, Michal L.
    AMERICAN JOURNAL OF NEPHROLOGY, 2015, 42 (01) : 25 - 34
  • [22] Age and Association of Kidney Measures With Mortality and End-stage Renal Disease
    Hallan, Stein I.
    Matsushita, Kunihiro
    Sang, Yingying
    Mahmoodi, Bakhtawar K.
    Black, Corri
    Ishani, Areef
    Kleefstra, Nanne
    Naimark, David
    Roderick, Paul
    Tonelli, Marcello
    Wetzels, Jack F. M.
    Astor, Brad C.
    Gansevoort, Ron T.
    Levin, Adeera
    Wen, Chi-Pang
    Coresh, Josef
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2012, 308 (22): : 2349 - 2360
  • [23] THE THYROID IN END-STAGE RENAL-DISEASE
    KAPTEIN, EM
    QUIONVERDE, H
    CHOOLJIAN, CJ
    TANG, WW
    FRIEDMAN, PE
    RODRIQUEZ, HJ
    MASSRY, SG
    MEDICINE, 1988, 67 (03) : 187 - 197
  • [24] Impact of dialysis modality on the survival of patients with end-stage renal disease and prior stroke
    I-Kuan Wang
    Wen-Miin Liang
    Cheng-Li Lin
    Yao-Lung Liu
    Chiz-Tzung Chang
    Tzung-Hai Yen
    Chiu-Ching Huang
    Fung-Chang Sung
    International Urology and Nephrology, 2016, 48 : 139 - 147
  • [25] Impact of dialysis modality on the survival of patients with end-stage renal disease and prior stroke
    Wang, I-Kuan
    Liang, Wen-Miin
    Lin, Cheng-Li
    Liu, Yao-Lung
    Chang, Chiz-Tzung
    Yen, Tzung-Hai
    Huang, Chiu-Ching
    Sung, Fung-Chang
    INTERNATIONAL UROLOGY AND NEPHROLOGY, 2016, 48 (01) : 139 - 147
  • [26] Impact of Socioeconomic Status on Incidence of End-Stage Renal Disease (ESRD) and Mortality following Dialysis in Patients with Diabetes
    Ke, Calvin
    Kim, S. Joseph
    Shah, Baiju R.
    Bierman, Arlene S.
    Lipscombe, Lorraine
    Feig, Denice S.
    Booth, Gillian L.
    DIABETES, 2017, 66 : A429 - A430
  • [27] Cardiovascular mortality in end-stage renal disease
    Collins, AJ
    AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 2003, 325 (04): : 163 - 167
  • [28] Depression and Mortality in End-Stage Renal Disease
    Halen, Nisha Ver
    Cukor, Daniel
    Constantiner, Melissa
    Kimmel, Paul L.
    CURRENT PSYCHIATRY REPORTS, 2012, 14 (01) : 36 - 44
  • [29] Depression and Mortality in End-Stage Renal Disease
    Nisha Ver Halen
    Daniel Cukor
    Melissa Constantiner
    Paul L. Kimmel
    Current Psychiatry Reports, 2012, 14 : 36 - 44
  • [30] Prediction of early death in end-stage renal disease patients starting dialysis
    Barrett, BJ
    Parfrey, PS
    Morgan, J
    Barre, P
    Fine, A
    Goldstein, MB
    Handa, SP
    Jindal, KK
    Kjellstrand, CM
    Levin, A
    Mandin, H
    Muirhead, N
    Richardson, RMA
    AMERICAN JOURNAL OF KIDNEY DISEASES, 1997, 29 (02) : 214 - 222